The Latest In Oxaloacetate Research
FDA Allows Oxaloacetate CFS Structure/Function ...
Based on the results of peer-reviewed clinical trials, doctor and patient reports and the existing body of research investigating Oxaloacetate, the U.S. Food and Drug Administration has allowed the following...
FDA Allows Oxaloacetate CFS Structure/Function ...
Based on the results of peer-reviewed clinical trials, doctor and patient reports and the existing body of research investigating Oxaloacetate, the U.S. Food and Drug Administration has allowed the following...
International ME/CFS Conference 2025 Features O...
At the International ME/CFS Conference 2025 in Berlin, Oxaloacetate CFS Chief Science Officer Alan Cash, a global leader of oxaloacetate research—delivered a compelling keynote on the potential of oxaloacetate medical...
International ME/CFS Conference 2025 Features O...
At the International ME/CFS Conference 2025 in Berlin, Oxaloacetate CFS Chief Science Officer Alan Cash, a global leader of oxaloacetate research—delivered a compelling keynote on the potential of oxaloacetate medical...
Alan Cash of Terra Biological to Present Breakt...
The 2025 International ME/CFS Conference, hosted by the ME/CFS Research Foundation, is set to feature a pivotal presentation by Alan Cash, Chief Science Officer of Terra Biological LLC. Scheduled for May...
Alan Cash of Terra Biological to Present Breakt...
The 2025 International ME/CFS Conference, hosted by the ME/CFS Research Foundation, is set to feature a pivotal presentation by Alan Cash, Chief Science Officer of Terra Biological LLC. Scheduled for May...
International ME/CFS Conference 2025 to Spotlig...
Berlin, Germany — Medical professionals, researchers, and global experts will converge—virtually and in-person—on May 12-13, 2025, for the International ME/CFS Conference, a two-day hybrid event dedicated to the latest developments...
International ME/CFS Conference 2025 to Spotlig...
Berlin, Germany — Medical professionals, researchers, and global experts will converge—virtually and in-person—on May 12-13, 2025, for the International ME/CFS Conference, a two-day hybrid event dedicated to the latest developments...
The Enhanced Responder Phenomenon with ME/CFS a...
More than 17 million people worldwide have ME/CFS and chronic fatigue. As medical care scrambles to find more effective treatments, the Bateman Horne Center finds that Oxaloacetate Therapy, under the...
The Enhanced Responder Phenomenon with ME/CFS a...
More than 17 million people worldwide have ME/CFS and chronic fatigue. As medical care scrambles to find more effective treatments, the Bateman Horne Center finds that Oxaloacetate Therapy, under the...
New Medical Food Provides Significant Improveme...
A recent randomized, controlled clinical trial conducted by the Bateman Horne Center and published in Frontiers in Neurology investigated the effects of oxaloacetate supplementation on patients with Myalgic Encephalomyelitis/Chronic Fatigue...
New Medical Food Provides Significant Improveme...
A recent randomized, controlled clinical trial conducted by the Bateman Horne Center and published in Frontiers in Neurology investigated the effects of oxaloacetate supplementation on patients with Myalgic Encephalomyelitis/Chronic Fatigue...